Alopecia Areata: JAK Inhibitors, PRP, and Exosomes

    January 2024 in “ Updates in clinical dermatology
    Doris Day
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Tofacitinib →

    a JAK inhibitor for alopecia areata and other autoimmune conditions

    Platelet-Rich Plasma →

    growth factors taken from your blood and injected into your scalp to stimulate hair

    Studysummary This paper reviews the autoimmune disorder alopecia areata, its progression, and its significant emotional and psychological impact, but reports no new clinical findings. Our plain-language summary of this paper — not a Tressless recommendation.
    The document discusses Alopecia Areata (AA), an autoimmune disorder affecting approximately 6.8 million people in the U.S., characterized by non-scarring hair loss in patches. It explores treatments like JAK inhibitors, platelet-rich plasma (PRP), and exosomes. JAK inhibitors, such as tofacitinib, have shown promise in hair regrowth by modulating immune responses. PRP therapy, which involves injecting concentrated platelets, is reviewed for its potential to stimulate hair growth. Exosomes derived from mesenchymal stem cells are highlighted for promoting hair regrowth by enhancing hair follicle cell proliferation and migration. The emotional impact of AA is significant due to societal views on hair.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results